Magdalena Mizera, Grzegorz Torbicz, Natalia Gajewska, Jan Witowski, Mateusz Rubinkiewicz, MD, PhD, Mateusz Wierdak, MD, Magdalena Pisarska, MD, Piotr Major, MD, PhD, Piotr Malczak, MD, Michal Pedziwiatr, MD, PhD. 2nd Department of General Surgery, Jagiellonian University Medical College, Cracow, Poland
Background: Transanal total mesorectal excision (TaTME) is emerging as a novel alternative to laparoscopic total mesorectal excision (LaTME). The aim of this study was to compare clinical and pathological results from these two techniques in patients undergoing rectal resections for low rectal cancer.
Materials and Methods: Thirty-five patients undergoing TaTME were matched with 35 patients operated on using LaTME. Composite primary endpoint (complete TME, negative circumferential resection margin [pCRM], and distal resection margin [pDRM]) was used to assess pathological quality specimens. Secondary outcomes included operative and postoperative parameters (operative time, total blood loss, postoperative morbidity, length of stay, 30-day mortality).
Results: Composite primary endpoint was achieved by 85% of subjects in the TaTME group and 82% of subjects in the LaTME group (p = 0.66). Mean pCRM was 1.1 ± 1.29 mm vs. 0.99 ± 0.78 mm (p = 0.25). Distal pDRM was 1.57 ± 0.92 cm and 1.98 ± 1.22 cm (p = 0.15). In the TaTME and LaTME groups, respectively. Complete mesorectal excision was achieved in 89% and 83% of subjects, while excision was nearly complete for the remaining 11% and 17% (p = 0.23). Secondary outcomes were not significantly different.
Conclusions: TaTME appears to be a non-inferior alternative to laparoscopic surgery. In comparison to LaTME, TaTME allows for similar quality of specimens with comparable clinical outcomes.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 94158
Program Number: P297
Presentation Session: Poster Session (Non CME)
Presentation Type: Poster